OPKO Health’s (OPK) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a report published on Monday morning,Benzinga reports. They currently have a $3.00 price objective on the biotechnology company’s stock. A number of other research analysts have also issued reports on OPK. StockNews.com lowered shares of OPKO Health from a […]
HC Wainwright reissued their buy rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a report published on Monday morning,Benzinga reports. They currently have a $3.00 price objective on the biotechnology company’s stock. A number of other research analysts have also issued reports on OPK. StockNews.com lowered shares of OPKO Health from a […]
